In a study published in Proceedings of the National Academy of Sciences, University of Alabama at Birmingham Department of Dermatology professors Chander Raman, Ph.D., and Mohammad Athar, Ph.D., and ...
According to an international multicenter study, CD2-negative mast cells are associated with significantly reduced overall survival in patients with SM. Patients with CD2-negative mast cells have ...
Investigational microbiota-based live therapeutic RBX2660 was found to be safe and effective at reducing Clostridioides difficile (C difficile) recurrence, said Paul Feuerstadt, MD, assistant clinical ...
Recent studies have highlighted the CD2-CD58 axis's relevance in cancer immunotherapy, suggesting its potential to enhance anti-tumor immunity and making it a promising target for therapeutic ...
TALAPRO-1: Talazoparib monotherapy in metastatic castration-resistant prostate cancer (mCRPC) with tumor DNA damage response alterations (DDRm)—Exploration of germline DDR alteration landscape and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results